Shoko Takano

Yokohama, 2360004, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors.

Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors.

Journal: Cancers

Published: March 22, 2026

Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.

Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.

Journal: International journal of clinical oncology

Published: January 08, 2026

Accelerating imaging: deep learning for enhanced 123I-ioflupane SPECT efficiency.

Accelerating imaging: deep learning for enhanced 123I-ioflupane SPECT efficiency.

Journal: Japanese journal of radiology

Published: September 26, 2025

A Report on Health Resource Use in Internal Radiation Therapy Using Lutetium-177 (177Lu)-PSMA-617

A Report on Health Resource Use in Internal Radiation Therapy Using Lutetium-177 (177Lu)-PSMA-617

Journal: Kaku igaku. The Japanese journal of nuclear medicine

Published: September 18, 2025

Evaluation of Reduced Single-Photon Emission Computed Tomography Imaging Protocols and Software Variability in 177Lu-DOTATATE Dosimetry: Protocol for an Exploratory Observational Trial.

Evaluation of Reduced Single-Photon Emission Computed Tomography Imaging Protocols and Software Variability in 177Lu-DOTATATE Dosimetry: Protocol for an Exploratory Observational Trial.

Journal: JMIR research protocols

Published: August 29, 2025

Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.

Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.

Journal: International journal of clinical oncology

Published: July 13, 2025

Pharmacokinetics and dosimetry of [177Lu]Lu-PSMA-617 and [68Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPC.

Pharmacokinetics and dosimetry of [177Lu]Lu-PSMA-617 and [68Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPC.

Journal: Annals of nuclear medicine

Published: April 03, 2025

Infectious Complications in Patients Receiving Superselective Intra-Arterial Chemoradiotherapy for Oral Squamous Cell Carcinoma.

Infectious Complications in Patients Receiving Superselective Intra-Arterial Chemoradiotherapy for Oral Squamous Cell Carcinoma.

Journal: Oral diseases

Published: February 28, 2025

Long-term Outcomes of Early-stage Non-stomach Gastrointestinal Mucosa-associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy.

Long-term Outcomes of Early-stage Non-stomach Gastrointestinal Mucosa-associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy.

Journal: Anticancer research

Published: March 30, 2023

Indications and Practice of a New Radionuclide Therapy, 177Lu-DOTATATE in Japan

Indications and Practice of a New Radionuclide Therapy, 177Lu-DOTATATE in Japan

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 01, 2022

Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors.

Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors.

Journal: Cancers

Published: May 21, 2022

Neuroendocrine tumor theranostics.

Neuroendocrine tumor theranostics.

Journal: Cancer science

Published: November 15, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026